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Progression of autosomal-dominant polycystic kidney disease to the many case reports of symptomatic, severe disease in
in children. early childhood [references in 1, 2], cross-sectional studies
Background. Although many case reports describe mani- have been performed in children who were examined withfestations of autosomal-dominant polycystic kidney disease
ultrasound and gene linkage analysis (GLA) because of(ADPKD) in children, no longitudinal studies have examined
a family history of ADPKD [3]. We have shown thatthe natural progression or risk factors for more rapid progres-
sion in a large number of children from ADPKD families. approximately 60% of children who carry the PKD-1 gene
Methods. Since 1985, we have studied 312 children from 131 have cysts detectable by ultrasound by five years of age
families with a history, a physical examination, blood and urine [4]. Among children aged 5 to 18 years, 75 to 80% ofchemistries, an abdominal ultrasonography, and gene linkage
the carriers of the PKD-1 gene have cysts by ultrasoundanalysis. One hundred fifteen of 185 affected children were stud-
imaging. In our previous study of 62 affected children,ied multiple times for up to 15 years. Renal volumes were deter-
mined by ultrasound imaging. Graphs of mean renal volumes 60% had between 1 and 10 renal cysts, and 40% had
according to age were compared between affected and unaf- more than 10 renal cysts at a mean age of 11 years [3].
fected children, ADPKD children with and without early severe
Children with more than 10 cysts were older than thosedisease, and children with and without high blood pressure.
with less than 10 cysts (mean age of 13 vs. 10 years) andResults. Affected children had faster renal growth than unaf-
fected children. ADPKD children with severe renal enlargement had enlarged kidneys [3]. These more severely affected
at a young age continued to experience faster renal growth children also had pain and hypertension more often than
than those with mild enlargement or normal kidney size for children with less than 10 cysts.
their age, and affected children with high blood pressure had
While these data have helped define the clinical spec-faster renal growth than those with lower blood pressure. Glo-
trum of ADPKD in childhood, there are few longitudi-merular filtration rate did not decrease in any children except
nal studies on the rate of progression and the factorsfor two with unusually severe early onset disease.
Conclusions. The progression of ADPKD clearly occurs in associated with progression in children. Previously, we
childhood and manifests as an increase in cyst number and renal reported limited follow-up findings in two groups of
size. This study identifies children at risk for rapid renal en-
ADPKD children: 11 with a PKD diagnosis in utero orlargement who may benefit the most from future therapeutic
in the first year of life and 22 diagnosed after the firstinterventions.
year of life by ultrasound screening [3]. The first group
of children had unusually severe disease, with two devel-
oping end-stage renal disease (ESRD) during childhood.Although autosomal dominant polycystic kidney dis-
Among the 22 children of the second group, there wasease (ADPKD) often is considered a disease of adults, it
an increase in cyst number over a mean interval of 3.7is clear that the disease begins in childhood. In addition
years, and two children developed systolic hypertension;
however, none had a decrease in renal function.
1 See Editorial by Avner, p. 1979. To describe more completely the natural progression
of the disease in childhood and to identify those children
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at greatest risk for progression, we undertook a longitu-aldosterone system, hematuria, hypertension, childhood renal disease
progression, cyst enlargement. dinal study of a large group of at-risk children. We hy-
pothesized that early severe disease, that is, severe renalReceived for publication March 23, 2000
enlargement and/or a large number of cysts at a youngand in revised form November 8, 2000
Accepted for publication December 1, 2000 age, would progress faster during childhood than mild
disease, characterized by mildly enlarged or normal kid-Ó 2001 by the International Society of Nephrology
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ney size and only a few cysts. Since renal function usually Kimberling using established markers for the PKD-1
and PKD-2 genes [4].remains normal in ADPKD children, the progression
was assessed by the rate of increase in renal volume During their two-day hospital stay, the children had
multiple blood pressure measurements obtained (meandetermined by ultrasound imaging. Renal volume as a
measure of disease severity is clinically relevant because 14, range 2 to 20); these were taken on the dominant
arm with an automatic device (Dynamap; Critikon, Inc.,the renal complications of ADPKD such as pain, hema-
turia, stones, hypertension, and ESRD are related to Tampa, FL, USA) in the sitting position using a cuff
appropriate for the child’s upper arm circumference.renal size [5–12]. We further hypothesized that hyperten-
sion, hematuria, and proteinuria would be associated These blood pressures were compared with established
standards of blood pressures for children of a given age,with more aggressive renal growth. This study addresses
these hypotheses. gender, and height (personal communication by Dr. Ros-
ner) [17]. High blood pressure (HBP) was defined as
50% or more of either systolic or diastolic in-house blood
METHODS
pressures above the 75th percentile for age-, gender-, and
Since 1985, all individuals who had taken part in the height-matched children, or being on antihypertensive
University of Colorado Natural History Study of ADPKD therapy, whereas normal blood pressure (NBP) was de-
were asked to have their children participate in an ongo- fined as more than 50% of both systolic and diastolic
ing longitudinal study. In addition, children with known blood pressures at or below the 75th percentile.
ADPKD were referred to us for participation in the All children had abdominal ultrasonography as pre-
study. The children and their affected parent were asked viously described [3]. Abdominal ultrasound was per-
to return for follow-up visits every three years. All chil- formed with a high-resolution real-time scanner (Acuson
dren were younger than 18 years at their first visit but 1.28 EXP with a 3.5 or 5.0 MHz transducer). The children
were followed up to their 20th birthday. Parents provided were considered to have ADPKD if they had at least a
informed consent, and all children over the age of seven single cyst by ultrasonography [18] or if they were pre-
years provided an assent. dicted to be gene carriers by linkage analysis. Renal
All children and their affected parent were admitted to volume was calculated as a modified ellipse from the
the Pediatric Clinical Research Center at The Children’s measurements obtained by ultrasound [3]. Since in this
Hospital or to the General Clinical Research Center at study only 5 of 185 children had markedly asymmetric
University Hospital in Denver for a 48-hour stay. All kidneys, that is, one kidney having more than double
children and parents underwent a standard history, phys- the volume of the other, we calculated the mean renal
ical examination, blood sampling for complete blood volume (MRV) for each child as the average of the two
count (CBC), routine chemistries, and gene linkage anal- kidneys. Renal volumes were determined at every visit
ysis (GLA), and collected 24-hour urine specimens for (on average every 3 years) for all affected and unaffected
creatinine, electrolytes, and protein as previously de- children.
scribed [13]. Six affected and four unaffected children To examine the relationship between MRV and age,
refused to have their blood drawn. we fitted several regression models to the data using the
Blood and urinary chemistry determinations were per- SPSS statistical software package (Chicago, IL, USA) to
formed by the Clinical Laboratories of University Hos- determine which gave the best fit [19]. All renal volumes
pital or The Children’s Hospital. Urinary protein con- obtained from all affected and unaffected children up to
centrations were measured using the Coumassie blue their 20th birthday were used for this analysis. Therefore,
dye-binding method [14]; urinary albumin concentra- children who were seen only once contributed only one
tions were measured since 1994 using a standard radioim- data point, whereas children with repeat visits contrib-
munoassay (Diagnostics Products, Los Angeles, CA, uted two to four data points (mean 2.2). The candidate
USA). Overt proteinuria was defined as urinary protein regression models were linear, quadratic, and growth.
excretion greater than 4 mg/m2 per hour [15]. Hypercalci- The model that produced the best fit (highest R 2) was
uria was defined as urinary calcium excretion greater the growth model (general form: y 5 eb01b1t) for both
than 4 mg/kg/day. Glomerular filtration rate (GFR) was affected and unaffected children, where t 5 age in years
calculated by the Schwartz formula GFR 5 (kxL)/PCr, and y 5 MRV in cm3.
where L is the length (height) of the child in cm, PCr the To determine the influence of gender, height, and age
serum creatinine concentration in mg/dL, and k 5 0.45 on MRV, the curves for MRV versus age were plotted
for children younger than two years, k 5 0.55 for children separately for boys and girls, with and without normaliza-
age 2 to 12 years and for girls age 13 to 18 years, and tion of MRV for height. The MRVs were normalized
k 5 0.70 for boys age 13 to 18 years old [16]. Blood was for height by dividing MRV by height (in cm) and multi-
also drawn for linkage analysis for PKD-1 and PKD-2. plying by 137 cm, which was the mean height of all the
children.These tests were performed in the laboratory of Dr.
Fick-Brosnahan et al: Progression of ADPKD in children1656
Fig. 1. Ultrasound findings and gene linkage
analysis (GLA) results in the study children
(1985 to 1999). Abbreviations are: US, ultra-
sound; GLA, gene linkage analysis; NA, not
available; 1, positive; 2, negative.
The relationship between MRV and age was also ex- RESULTS
amined in children with early severe disease and in af- Three hundred twelve children from 131 families were
fected children without early severe disease. We arbi- studied from July 1985 to September 1999. One hundred
trarily categorized children as having early severe disease forty-two children were from PKD-1 families and four
if at the first visit their MRV was greater than 25% above were from PKD-2 families; for the other children, GLA
the growth curve for MRV of all affected children. This results were not available. Figure 1 shows the ultrasound
resulted in approximately 17% of the affected children and GLA findings of all children. Only three children
being categorized as having early severe disease. Choos- had positive GLA results without detectable cysts by
ing greater than 50% above the mean for age would ultrasound. One is a 14-year-old boy from a PKD-2 fam-
result in only eight children classified as early severe ily, and the other two are from PKD-1 families, a 9-year-
disease. For this specific analysis, only the children who old girl and a 16-year-old boy (this young man still did
had at least one follow-up visit were included; therefore, not have any cysts when he returned at age 23 years).
all children contributed at least two data points. Two of the four children from PKD-2 families were unaf-
To examine the influence of blood pressure on renal fected. Two were affected: One boy had a positive ultra-
growth, renal volume data were plotted for children sound at age eight years, and the other was the 14-year-
with blood pressure values above the 75th percentile at old predicted gene carrier with a negative ultrasound.
the first and last visit compared with children with NBP. Of the 182 ultrasound-positive children, 91 were diag-
The MRVs at the first and last visit were included in this nosed with the disease during a study visit, and the other
analysis. 91 presented with known ADPKD. Parents reported
For each of the growth curves, the standardized b co- several reasons for ultrasound evaluation of these pre-
efficients were used to test for significant differences viously diagnosed children, including an abdominal mass,
in slopes between the curves (for example, affected vs. hematuria, pain, urinary tract infection, frequency, hy-
unaffected, boys vs. girls, early severe vs. not severe, pertension, an obstructing ureteral stone, and pregnancy
HBP vs. NBP). The z-test was used after application of in one teenage girl; 26 children were screened only be-
Fisher’s Z-transformation. cause of a family history of ADPKD.
For a paired data analysis in individual children, the One hundred eight of the 182 ultrasound-positive chil-
increase in renal volume per year was determined be- dren had multiple visits before their 20th birthday. The
tween the first and last visit. The changes in MRV were mean age at the initial visit was 8.2 6 0.4 years and at
compared by analysis of covariance (ANCOVA) be- the final visit was 13.9 6 0.5 years for a mean follow-up
tween children with or without early severe disease, with of 5.7 years. Sixty-seven of the 127 unaffected children
more or less than 10 cysts before age 12 years, and had multiple visits. The mean age at the initial visit was
between children with high or NBP. Because the early 7.7 6 0.5 years and at the final visit was 12.2 6 0.6 years
severe disease children were significantly younger than for a mean follow-up of 4.6 years. The affected children
the other children at the initial as well as the final visit, who did not return for a follow-up visit were older (9.9 6
renal volumes were linearly adjusted for age using 0.6 vs. 8.2 6 0.4 years, P , 0.05), had larger renal volumes
ANCOVA. We also compared MRV at the last visit even when adjusted for age (142 6 8 vs. 114 6 6 cm3;
between ADPKD children with and without overt pro- P , 0.05), were more frequently hypertensive (36 vs.
teinuria and between children with and without a history 17%, P , 0.005), and had a greater frequency of gross
hematuria (16 vs. 7%, P , 0.05) than affected childrenof gross hematuria, using ANCOVA.
Fick-Brosnahan et al: Progression of ADPKD in children 1657
Fig. 2. Ultrasound findings in 185 autosomal
dominant polycystic kidney disease (ADPKD)
children at their first visit and at follow-up.
Abbreviations are: US, ultrasound; GLA, gene
linkage analysis.
who returned for follow-up visits. There was no gender
difference between children who did or did not return.
Figure 2 shows the development of renal cysts with
age. One hundred sixty-six children had a positive ultra-
sonogram at their first visit, and 154 of them had multiple
renal cysts. They were older at their first visit than the
19 children who initially had a negative ultrasonogram.
Sixteen of these 19 children had renal cysts at a later visit.
Of the 12 children with a single cyst at their first visit, 11
progressed to bilateral cysts at a subsequent visit.
Increasing cyst numbers cause an increase in renal
volume. To assess the progression of the renal disease
in these children, we determined renal volumes longitu-
dinally. Because renal volumes of healthy children in-
Fig. 3. Relationship between mean renal volume (MRV; cm3) and age
crease as the children grow, it is important to compare (years) in 182 affected (solid line; ultrasound-positive) and 127 unaf-
fected (dashed line) children who had one to four visits before the agerenal volumes of affected and unaffected children at a
of 20 years. The regression model that gave the best fit for the datagiven age. Figure 3 shows the relationship between
was the growth model. The equation for the affected children is MRV 5
MRVs and age for affected and unaffected children. The e3.67910.1033age, with R 2 5 0.61; for the unaffected children MRV 5
e3.39910.0953age, with R 2 5 0.77. The b coefficients of the growth curvesregression model that gave the best fit for the data was
differ significantly (1.38 vs. 1.05; P , 0.001) between the affected andthe growth model (general form: y 5 eb01b1t), as described
unaffected children, with the curve for the affected children being
in the Methods section. The equations for the curves are steeper, indicating that renal volume increases faster over time in the
affected than the unaffected children.given in the figure legends. The b coefficients of the
growth curves differed significantly (1.38 vs. 1.05, P ,
0.001) between the affected and unaffected children, with
the curve for the affected children being steeper, indicat- the regression lines (the growth model) are plotted in
ing that renal volume increases faster over time in the black dots, whereas the actual data points are plotted in
affected than the unaffected children. The growth model gray. Figure 4B also shows that renal volumes no longer
also implied that renal volume enlarges faster at an older increase after age 18 years in unaffected children (as
age in the affected children. Since R 2 was larger for the shown by the gray dots; the black dots are fitted to the
unaffected than for the affected children, the model was growth model), whereas the kidneys continue to enlarge
a better fit for the unaffected children. This was an indica- in the affected children.
tion of the greater variability of renal volumes for a given We sought to identify factors that were associated with
larger renal volumes and/or a faster increase in renalage in the affected children, as shown in Figure 4, where
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Fig. 4. (A) Scatter plot of individual MRV in affected children ac-
cording to age. The growth model is represented by the black dots, Fig. 5. (A) Relationship between MRV normalized for height and age
whereas the actual data are plotted in gray. (B) Scatter plot of individual in 46 unaffected boys (solid line) and 81 unaffected girls (dashed line).
MRV in unaffected children according to age. The growth model is rep- The equation for boys is: MRV 5 e3.93710.0513age, with R 2 5 0.45; for girls
resented by the black dots, whereas the actual data are plotted in gray. MRV 5 e3.86210.0493age, with R 2 5 0.57. The curves and the b coefficients
(0.97 vs. 0.81 for boys vs. girls) are not significantly different, indicating
that the height-normalized MRV of unaffected boys and girls are similar
and increase at a similar rate (the same is true when MRV are not
normalized for height). (B) Relationship between MRV normalized for
volume with age. Therefore we examined whether gen- height and age in 90 affected boys and 92 affected girls. The equation
for boys is: MRV 5 e4.24610.0483age, with R 2 5 0.27; for girls MRV 5der influenced renal volume. Figure 5 shows that affected
e4.08910.0653age, with R 2 5 0.34. The curves and the b coefficients (0.67 vs.and unaffected boys and girls had similar renal volumes 0.58 for boys vs. girls) are not significantly different, indicating that the
at any given age; this was true whether the renal volumes height-normalized MRV of affected boys and girls are similar and
increase at a similar rate (the same is true when MRV are not normalizedwere normalized for height or not.
for height).We examined whether children with early severe dis-
ease have faster renal growth than children with initially
mild disease. One hundred eight affected children had
disease had significantly larger increases in age-adjustedat least one follow-up visit before the age of 20 years;
MRV per year than those with mild disease.30 of them had early severe disease (kidneys at least
When using cyst numbers before age 12 years as the
25% larger than the mean for age at the initial visit). criterion for severe or mild disease and comparing renal
Seventy-eight did not have early severe disease. Figure 6 growth between visits, the results were similar. Table 1
shows the renal volume–age relationship for these chil- shows the changes in absolute and age-adjusted renal
dren. Again, the growth model was the best fit for the volumes per year for children with 10 or more cysts be-
data. The curve for the “early severe” children was sig- fore age 12 years [severe ADPKD (SADPKD)] com-
nificantly steeper, indicating that these children had a pared with children with less than 10 cysts until after
faster renal enlargement than the children with mild age 12 years [mild ADPKD (MADPKD)]. SADPKD
disease. This observation was confirmed by the paired children had a significantly larger increase in renal vol-
ume per year than MADPKD children (P , 0.01).data analysis (Table 1). The children with early severe
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14 had one episode, and 5 had several episodes of gross
hematuria. As inciting events for gross hematuria the
parents reported a urinary tract infection in six children,
taking part in sports in five, and no precipitating event
in six children. Hypercalciuria was not more common in
children with hematuria than in those without (6 and
16%, P 5 NS), and it was not more common in affected
(15%) than unaffected (25%) or in hypertensive (13%)
than normotensive (16%) children (P 5 NS). The in-
crease in renal volume between visits was not different
between children with and without a history of gross he-
maturia. However, a cross-sectional comparison at the last
visit showed that children with a history of gross hematuria
had significantly larger kidneys than children without such
Fig. 6. Mean renal volume according to age in 108 ADPKD children a history, despite their similar ages (Table 3).
who had two or more visits before age 20 years, separated into curves
We examined whether the size of the largest cyst cor-for 30 children with early severe disease (—) and 78 children who did
not have early severe disease (- - -). For the “early severe” children related with gross hematuria, pain, or hypertension. The
MRV 5 e3.86310.1313age, R 2 5 0.89. For the children with mild disease diameter of the largest cyst correlated with age (r 5
MRV 5 e3.39510.1073age, R 2 5 0.79. The b coefficients of the curves were
0.31, P , 0.0001), but not with pain or gross hema-significantly different (1.74 vs. 1.40, P , 0.05), with the curve of the
early severe children being significantly steeper, indicating significantly turia. Hypertension was associated with a larger cyst
faster renal growth. diameter (age-adjusted 3.1 6 0.2 cm vs. 2.0 6 0.1 cm,
P , 0.0001), but this was not independent from the
effects of larger MRVs.
The mean Schwartz GFRs at the last visit were similarThere were only 17 children with blood pressures above
in affected versus unaffected children (135 vs. 129 mL/min/the 95th percentile who had renal volume data obtained
1.73 m2), in children with early severe disease comparedfrom a subsequent visit; therefore, we did not have
with the children with mild disease (132 vs. 136 mL/min/enough data to construct growth curves for these chil-
1.73 m2), in children with HBP above the 75th percentiledren. However, there were 33 children with blood pres-
compared with those with NBP (133 vs. 137 mL/min/sures above the 75th percentile at the first and last visit
1.73 m2), in children with or without overt proteinuriaand 37 children with blood pressures below the 75th per-
(135 mL/min/1.73 m2 for both), and in children with orcentile at both visits (NBP). Figure 7 shows that the chil-
without gross hematuria (141 vs. 134 mL/min/1.73 m2).dren with HBP above the 75th percentile had a signifi-
Except for two children with hypertension and ADPKDcantly steeper slope of the age–volume relationship curve
diagnosed during the first month of life, there was nothan the children with NBP. Similarly, the change in age-
decline in Schwartz GFR in any child or young adult upadjusted renal volume per year was significantly greater
to 25 years of age, and there was no correlation betweenin the HBP above the 75th percentile than in the NBP
MRV and GFR.children (P , 0.01; Table 2). However, the children with
HBP above the 75th percentile had significantly larger
kidneys at their initial visit than the children with NBP. DISCUSSION
When the increase in renal volume was adjusted for age The progression of ADPKD to ESRD is highly variable,
and initial renal volume, the difference between the HBP with age at onset of ESRD ranging from childhood to
above the 75th percentile and NBP children was no old age [12]. In adults, several risk factors for faster pro-
longer significant. gression have been identified, including the PKD-1 gene,
Children with overt proteinuria at the last visit had sig- male gender, a younger age at diagnosis, the presence of
nificantly larger kidneys than children without overt pro- hypertension, hematuria, and proteinuria, a younger age
teinuria (Table 3). The two groups were similar in age at onset of hypertension and hematuria, larger kidneys,
and gender. There was no significant difference in the and a younger age at incipient renal failure [12, 20–22].
increase in renal volume in children with overt protein- The disease course and risk factors for progression have
uria at the initial visit compared with those without pro- not been described in a large series of children. Because
teinuria at the initial visit, possibly because the number the disease starts in childhood and progresses to ESRD
of children with proteinuria at the initial visit and a over decades, identifying risk factors early, that is, in
follow-up sonogram was small (N 5 21). children, might provide the greatest potential for effec-
Gross hematuria occurred in 19 (10%) ADPKD chil- tive intervention in high-risk patients.
The progression of ADPKP in children cannot be as-dren at a mean age of nine years (range 0 to 18 years);
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Table 1. Change in mean renal volume (MRV) per year in ADPKD children with severe disease in early childhood compared with
ADPKD children with moderate disease
Initial age Follow-up age Age-adjusted initial Change in MRV/year Change in age-adjusted
N years MRV, cm3 cm3 MRV/year, cm3
Severe disease defined as initial renal volume .25% above the mean for age
Early severe 30 5.860.9 11.560.9 14865 11265 12663
Not severe 78 8.460.4 13.560.4 7963 11061 11162
P value ,0.005 ,0.05 ,0.0001 50.05 ,0.0001
Severe disease (SADPKD) defined as $10 renal cysts before age 12 years (MADPKD: ,10 cysts until after age 12 years)
SADPKD 48 5.860.5 11.460.6 10166 11662 11962
MADPKD 21 10.860.6 16.560.5 80611 11061 1463
P value ,0.0001 ,0.0001 NS ,0.01 ,0.0001
Indeed, the data shown in Figure 6 and Table 1 suggest
that the impact of such factors starts early in the course
of the disease and has an ongoing effect, as children who
already have enlarged kidneys at a young age had a much
steeper increase in their renal volumes than children with
normal-sized kidneys for their age. Moreover, 7 of the
30 children with early renal enlargement were diagnosed
in utero with enlarged, hyperechogenic kidneys, and 10
were diagnosed with ADPKD in the first 18 months of
life, usually because a symptom prompted an ultrasound
investigation. This also indicates the early impact of risk
factors leading to an increased renal growth rate.
For clinical practitioners, it might be difficult to deter-
mine whether a child’s kidneys are enlarged for age, but
Fig. 7. Mean renal volume according to age in 33 ADPKD children assessing cyst numbers by ultrasound is relatively easywith blood pressures above the 75th percentile at the first and last visit
in children because they have only a limited number of(HBP 75; —) and 37 ADPKD children with blood pressures below the
75th percentile at both visits (NBP; - - -). For the HBP 75 children cysts and preserved kidney architecture. Therefore, we
MRV 5 e3.76510.1073age, with R 2 5 0.65; for the NBP children MRV 5 examined whether it was possible to determine risk fore3.57010.0993age, with R 2 5 0.70. The b coefficients of the curves were
progression by using cyst numbers before the age of 12significantly different (1.22 vs. 1.11, P , 0.05), with the curve of the
HBP 75 children being significantly steeper, indicating significantly years as the criterion for disease severity. Our previous
faster renal growth than the NBP children. studies had shown that most children have less than 10
cysts before 12 years of age [3]. Therefore, we classified
children with 10 or more cysts before the age of 12 years
as SADPKD and those with less than 10 cysts until agesessed by the measurement of GFR. Our study shows
12 years as MADPKD. This classification is supported bythat renal function does not decline in childhood, with
our previous cross-sectional studies that demonstratedthe rare exceptions of some children who are born with
significant clinical differences between these groups ofenlarged kidneys and have early onset hypertension [1].
children [3]. Table 1 shows the changes in absolute andHowever, in this study, we show that structural progres-
age-adjusted renal volumes per year for SADPKD andsion in terms of an increase in cyst number and kidney
MADPKD children. SADPKD children had a signifi-size clearly occurs in childhood. Utilizing the rate of renal
cantly larger increase in renal volume per year thanenlargement as a marker for disease progression is clini-
MADPKD children (P , 0.01). This is remarkable con-cally relevant because much of the morbidity of ADPKD
sidering that the SADPKD children were significantlyis associated with large kidneys, particularly pain [5–7],
younger at their first and last visits than the MADPKDhematuria [8], stones [9], hypertension [10, 11], protein-
children and that most SADPKD children were prepu-uria [22], and progression to ESRD [12].
bertal, whereas most MADPKD children were after pu-In this regard, affected children have larger kidneys
berty, that is, after the pubertal growth spurt. This con-than their unaffected siblings at all ages. Moreover, there
firms that a large cyst number in early childhood is ais great variability of renal volumes at any given age
predictor for faster structural progression.among affected children (Fig. 4A), which indicates vary-
High blood pressure also identifies children who willing rates of renal enlargement. This suggests that risk
factors for faster renal enlargement may be identifiable. have faster renal growth. Our data show that ADPKD
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Table 2. Change in age-adjusted mean renal volume (MRV) per year in ADPKD children with high and normal blood pressure values
Change in MRV/year,
Initial MRV Change in age- adjusted for age
Initial age Follow-up age adjusted for agea adjusted MRV/year and initial MRV
N years cm3
HBP 75 33 7.460.8 13.060.8 12567 11962 11662
NBP 37 8.660.6 13.660.6 8366 11162 11462
P value NS NS ,0.0001 ,0.01 NS
High blood pressure (HBP 75) was defined as $50% of systolic or diastolic in-house blood pressures above the 75th percentile for age-, gender- and height-
matched children at the first and the last visit. Normal blood pressure (NBP) was defined as .50% of both systolic and diastolic blood pressures below the 75th
percentile at both the first and last visit.
a When initial MRV was adjusted for age and height, the numbers for MRV were the same
Table 3. Mean renal volumes (MRV) at the last visit in in school-age children [15]. In contrast, 28% of the
ADPKD children with (Pr1) and without (Pr2) proteinuria
ADPKD children and 35% of those with more than 10(at the last visit) and in children with (GH1) and without (GH2)
a history of gross hematuria cysts have overt proteinuria (P , 0.01 and P , 0.005 vs.
unaffected, respectively). In this study, overt proteinuriaMRV Age-adjusted MRV
was not correlated with hypertension, and all proteinuric
N Age years cm3
children have normal renal function. The pathophysiologic
Pr1 46 13.160.4 219623 215614 significance of overt proteinuria in ADPKD children isPr2 115 12.760.4 16469 16569
unclear.P value NS ,0.05 ,0.005
Gross hematuria has been described as a risk factor forGH1 19 13.460.8 251637 232621
GH2 162 11.860.4 16168 16367 faster progression in ADPKD adults [8, 12, 20]. Hematuria
P value NS ,0.05 ,0.005 is not common in children, as it occurred in only 10% of
affected children at a mean age of nine years. Children
with a history of hematuria had larger kidneys at the last
visit than those without hematuria despite similar age.
children with blood pressures above the 75th percentile The data are insufficient to determine whether hematuria
for age-, gender-, and height-matched children have a contributes to accelerated renal growth or is a manifesta-
greater annual increase in renal volume than ADPKD tion of more severe disease. Renal stones as a cause of
children with consistently lower blood pressure. How- hematuria are very rare in ADPKD children. Only one
ever, the children with higher blood pressure had larger
of our 185 children had documented obstructing ureteral
kidneys despite similar age to begin with, suggesting
stones at the age of 13 years. This boy also has markedmore severe disease. The link between structural severity
hypercalciuria, demonstrating the need for a metabolicand hypertension is likely, at least in part, because of
evaluation of an ADPKD child with nephrolithiasis.the up-regulation of the intrarenal renin-angiotensin-
In summary, we have shown that structural progres-aldosterone system (RAAS) [23–27]. Renin is overex-
sion of ADPKD occurs in childhood. Moreover, thispressed in polycystic kidneys [28–30]. It is found in high
study identifies characteristics in ADPKD children thatconcentrations in cyst fluid, and cystic epithelia have the
predict faster renal growth. Risk factors are renal en-ability to synthesize renin [30]. This could account for
largement early in life, having more than 10 renal cystsexcess renal angiotensin II production in children with
before age 12 years, and having blood pressures abovelarger kidneys and more cysts, leading to HBP. In turn,
the 75th percentile for age, height, and gender. Becauseangiotensin II is a growth factor for renal tubular cells
large kidneys are associated with increased morbidity[31–34] and enhances the mitogenic actions of epidermal
and progression to ESRD [6, 12], reducing renal growthgrowth factor (EGF) [32]; thus, angiotensin II may main-
should be considered an important therapeutic goal andtain a faster renal growth rate in hypertensive children
would ideally start in childhood. This study identifies thewith enlarged kidneys.
children who would benefit the most from such therapeu-Although this study could not determine whether overt
tic interventions.proteinuria predicts faster renal growth, overt protein-
uria was associated with a larger renal volume at the last
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